UBEN, a CD13/aminopeptidase N inhibitor, has been used in adjuvant chemotherapy as an excellent anticancer immunopotentiator and has been found to have cytotoxic effects in several cancer-cell lines41–44. The gene discussed is ANPEP; the disease is cancer.